Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2003
08/14/2003WO2003031416A3 [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
08/14/2003WO2003030935A3 Adjuvants for nucleic acid vaccines
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003015699A3 Topical compositions and methods for treating pain
08/14/2003WO2003013655A3 Carbonic anhydrase inhibitors
08/14/2003WO2003012060A3 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
08/14/2003WO2003012051A8 Inhibitor of dna methylation
08/14/2003WO2003002713A3 Antibodies to opgl
08/14/2003WO2003002129B1 Use of sulodexide for the treatment of inflammatory bowel disease
08/14/2003WO2003001984A3 Method and apparatus for the photomodulation of living cells
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002096374A3 Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
08/14/2003WO2002092849A3 Methods
08/14/2003WO2002083176A3 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
08/14/2003WO2002081005A3 Peritoneal dialysis fluid
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/14/2003WO2002058733B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
08/14/2003WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/14/2003WO2002052036A3 Identification of modulators of dham-kinase and inflammatory diseases
08/14/2003WO2002043807A3 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction
08/14/2003WO2002038142A3 Serotonergic compositions and methods for treatment of mild cognitive impairment
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002024887A3 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002015933A3 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
08/14/2003WO2002013866A9 Stimulating neutrophil function to treat inflammatory bowel disease
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090421A3 Method of detecting inflammatory lung disorders
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153629 Suppressing biosynthesis of exotoxins using terpenes selected from terpineol, beta-ionone, terpin, linalool, geraniol or menthol, and etherified polyoxyalkylene glycols
08/14/2003US20030153626 Administering antiestrogens, adenosine receptor and calmodulin antagonists for prophylaxis of vision defects
08/14/2003US20030153625 Suppressing bone disordes such as decalcification or fractures in humans having prostate gland cancers by administering antiestrogen selected from triphenylethylene or toremifene; hormone inhibitors
08/14/2003US20030153624 Racemic mixtures of N-(prop-2-ynyl)-2-aminophenylpropane, used for the prophylaxis of neurodegenerative disorders and as immunomodulators
08/14/2003US20030153613 Hypotensive agents for eye, using an aclurea indole compounds, potassium channel blockers; glaucoma
08/14/2003US20030153609 C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
08/14/2003US20030153590 Method of treating alcoholism or alcohol abuse
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153553 Quinoline derivatives
08/14/2003US20030153542 Novel anti-inflammatory androstane derivative compositions
08/14/2003US20030153541 Liver X receptor modulator comprising an oxysterol, lipid regulating HMG-CoA reductase inhibitor, fibric acid derivative, niacin, bile-acid sequestrant, probucol, raloxifene, unsaturated omega-3 fatty acid
08/14/2003US20030153539 Use of estramustine phosphate or a metabolite thereof in preparation of anticarcinogenic agent
08/14/2003US20030153536 Compounds and methods of treating transplant rejection
08/14/2003US20030153529 Dextrin containing compositions for prevention of adhesions
08/14/2003US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153521 Nucleic acid treatment of diseases or conditions related to levels of Ras
08/14/2003US20030153518 Activation and inhibition of the immune system
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003US20030153514 Anticarcinogenic agents has a saccharide having steric structure, activating natural killer T cell ability; food supplements
08/14/2003US20030153509 Inhibiting the dipeptidylpeptidase proteolysis of Glucagon-like peptide, by administering a dipeptides consisting Pro-Pro, Ala-Pro, and (D)-Ala-(L)-Ala; treating metabolism disorders, diabetes, obesity, atherosclerosis
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153497 A polypeptides and polynucleotides encoding the polypeptides, for obesity, insulin resistance, type 2 diabetes, cachexia
08/14/2003US20030153086 Such as iron hydroxide and sodium iron gluconate in glucose; blood disorders; storage stability
08/14/2003US20030153072 Culturing spermatogonial stem cells in the presence of BMP8 (bone morphogenetic protein-8) or a biologically active fragment or an agonist to effect proliferation of mammal spermatogonial stem cells
08/14/2003US20030153066 Isolating nucleic acid putatively encoding the viral gene from the viral genome; programming a cell-free translation system with such nucleic acid, determine if capsid assembly has occurred which indicates that viral gene is required
08/14/2003US20030153018 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
08/14/2003US20030153002 Ribosome structure and protein synthesis inhibitors
08/14/2003US20030152986 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152970 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/14/2003US20030152664 Microbiocides fatty acid mixed with feed
08/14/2003US20030152646 Central nervous system disorders; Alzheimer's and Parkinson'sdisease; administering tumor necrosis factor antagonist
08/14/2003US20030152643 Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunctions
08/14/2003US20030152642 Mixture of chondroitin sulfate, glucosamine and hyaluronic acid
08/14/2003US20030152628 Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in an immediate-release layer with levodopa ethyl ester in a controlled release core
08/14/2003US20030152617 Capsule, tablet with enteric, protective coatings; bioavailability
08/14/2003US20030152615 Enhanced drug delivery in transdermal systems
08/14/2003US20030152614 Enhanced drug delivery in transdermal systems
08/14/2003US20030152613 Steroid on carrier containing pressure sensitive adhesive
08/14/2003US20030152596 Mixture of elastase inhibitor and fungicide or bactericide; antiinflammatory agent
08/14/2003US20030152574 Modulate nucleic acid gene expression
08/14/2003US20030152571 Anti-alphabeta3 humanized monoclonal antibodies
08/14/2003US20030152566 Soluble CD40L (CD154) as a prognostic marker of atherosclerotic diseases
08/14/2003US20030152563 Administering plasminogen activator; biocompatiblity coupling to red blood carrier; drug delivery
08/14/2003US20030152557 Methods for inhibiting histone deacetylase-4
08/14/2003US20030152552 Synergistic mixture; viricides, antiproliferative agents, antiinflammatory agents; side effect reduction
08/14/2003DE3546944C2 Synergistic analgesic and antiinflammatory compsn.
08/14/2003CA2776902A1 Salts of valsartan
08/14/2003CA2697599A1 Method of treating and preventing bone loss
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2476281A1 Pyrimidine compounds
08/14/2003CA2476275A1 Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate cns nerve regeneration
08/14/2003CA2476214A1 Proliferated cell lines and uses thereof
08/14/2003CA2475839A1 Combination therapy for treatment of schizophrenia
08/14/2003CA2475446A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003CA2475377A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475277A1 Method for producing recombinant proteins in micro-organisms
08/14/2003CA2475209A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003CA2475112A1 Anti-infarction molecules
08/14/2003CA2475108A1 Treating benign prostate hyperplasia with sarms
08/14/2003CA2475066A1 Rhamnose binding protein
08/14/2003CA2474921A1 Pharmaceutical tablet
1 ... 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 ... 1151